LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion through acquisition Aerie Pharmaceuticals was recently acquired by Alcon for $770 million, indicating potential partnership opportunities with Alcon's extensive network and resources in the ophthalmic space.

New leadership roles Aerie Pharmaceuticals has appointed new key personnel like Chief Financial Officer and Chief Medical Officer, presenting opportunities to engage with the leadership team for collaboration and product initiatives.

Focus on eye care innovation With a focus on first-in-class therapies for eye diseases, Aerie Pharmaceuticals is a promising partner for companies looking to innovate in the ophthalmic pharmaceutical sector and address unmet medical needs.

Technology-driven operations Aerie Pharmaceuticals utilizes a variety of tech tools like SiteCatalyst, React, and AWS, showcasing a tech-savvy approach that aligns well with companies providing complementary technology solutions for pharmaceutical businesses.

Strong financial standing Aerie Pharmaceuticals reports annual revenue between $100 million to $1 billion, signifying a financially stable organization capable of investing in collaborations and partnerships, presenting an attractive target for potential sales agreements.

Similar companies to Aerie Pharmaceuticals

Aerie Pharmaceuticals Tech Stack

Aerie Pharmaceuticals uses 8 technology products and services including SiteCatalyst, Google Analytics, WordPress, and more. Explore Aerie Pharmaceuticals's tech stack below.

  • SiteCatalyst
    Analytics
  • Google Analytics
    Analytics
  • WordPress
    Content Management System
  • React
    Javascript Frameworks
  • Google Charts
    Javascript Graphics
  • Microsoft
    Miscellaneous
  • Amazon Web Services
    Platform As A Service
  • Akamai Bot Manager
    Security

Media & News

Aerie Pharmaceuticals's Email Address Formats

Aerie Pharmaceuticals uses at least 1 format(s):
Aerie Pharmaceuticals Email FormatsExamplePercentage
FLast@aeriepharma.comJDoe@aeriepharma.com
96%
LastFir@aeriepharma.comDoeJoh@aeriepharma.com
1%
FirstLast@aeriepharma.comJohnDoe@aeriepharma.com
2%
First-Last@aeriepharma.comJohn-Doe@aeriepharma.com
1%

Frequently Asked Questions

Where is Aerie Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Aerie Pharmaceuticals's main headquarters is located at 4301 Emperor Blvd. Durham, NC 27703 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Aerie Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Aerie Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aerie Pharmaceuticals's stock symbol?

Minus sign iconPlus sign icon
Aerie Pharmaceuticals is a publicly traded company; the company's stock symbol is AERI.

What is Aerie Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Aerie Pharmaceuticals's official website is aeriepharma.com and has social profiles on LinkedIn.

How much revenue does Aerie Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of March 2024, Aerie Pharmaceuticals's annual revenue reached $750M.

What is Aerie Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Aerie Pharmaceuticals's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Aerie Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of March 2024, Aerie Pharmaceuticals has approximately 501 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer And Board Member: R. K.Chief Executive Officer: T. H.Chief Research & Development Officer: D. A. H.. Explore Aerie Pharmaceuticals's employee directory with LeadIQ.

What industry does Aerie Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Aerie Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Aerie Pharmaceuticals use?

Minus sign iconPlus sign icon
Aerie Pharmaceuticals's tech stack includes SiteCatalystGoogle AnalyticsWordPressReactGoogle ChartsMicrosoftAmazon Web ServicesAkamai Bot Manager.

What is Aerie Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Aerie Pharmaceuticals's email format typically follows the pattern of . Find more Aerie Pharmaceuticals email formats with LeadIQ.

How much funding has Aerie Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of March 2024, Aerie Pharmaceuticals has raised $88M in funding. The last funding round occurred on Dec 07, 2021 for $88M.
Aerie Pharmaceuticals

Aerie Pharmaceuticals

Pharmaceutical ManufacturingNorth Carolina, United States501-1000 Employees

Inspiration, imagination, and innovation. We share this passion for finding new approaches to protecting vision. United by great science, deep clinical insight, and a singular focus on your ophthalmic needs, we see the possibilities ahead and invite you to join us in creating the future of eye care.

Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, dry eye, retinal diseases and other diseases of the eye.
 
See the future of eye care with Aerie.

Section iconCompany Overview

Headquarters
4301 Emperor Blvd. Durham, NC 27703 US
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
Stock Symbol
AERI
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
501-1000

Section iconFunding & Financials

  • $88M

    Aerie Pharmaceuticals has raised a total of $88M of funding over 11 rounds. Their latest funding round was raised on Dec 07, 2021 in the amount of $88M.

  • $100M$1B

    Aerie Pharmaceuticals's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $88M

    Aerie Pharmaceuticals has raised a total of $88M of funding over 11 rounds. Their latest funding round was raised on Dec 07, 2021 in the amount of $88M.

  • $100M$1B

    Aerie Pharmaceuticals's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.